Coexistence of renal cell carcinoma and malignant lymphoma: A causal relationship or coincidental occurrence?
Authors:
Open Access
Abstract
BACKGROUND Secondary malignant neoplasms are increasingly being observed in cancer populations and a considerable amount of data have accumulated in the literature. Among the secondary malignant neoplasms that occur with a higher incidence in cancer patients are lymphomas and renal cell carcinoma (RCC), as well as melanoma, lung/bronchus carcinoma. METHODS The authors analyzed the patient population at the Memorial Sloan‐Kettering Cancer Center in New York City between 1985 and 1995 for coexisting carcinomas, and identified 15 patients who had both RCC and malignant lymphoma among a total of 1262 patients with RCC and 1660 patients with malignant lymphoma. The occurrence and time of diagnosis of both malignant neoplasms and their clinical features, types, and stages, as well as short term follow‐up results, are presented. RESULTS The data show a greater than coincidental coexistence of RCC and malignant lymphoma (P < 0.01). In addition, there was a significant increase in the number of patients with both melanoma and RCC (P < 0.01), as well as melanoma and malignant lymphoma (P < 0.01). No significant increase was found in cases of coexisting RCC or malignant lymphoma with either lung/bronchus carcinoma or colorectal carcinoma (P > 0.05). CONCLUSIONS Causes of this increased coexistence may include a genetic predisposition to cancer, similar immune mechanisms associated with these neoplasms, closer scrutiny of this group of patients, or a combination of these factors. Studies are underway to elucidate a common genetic component in these patients. Cancer 1996;77:2325‐31.Keywords
This publication has 17 references indexed in Scilit:
- Risk of kidney cancer and other second solid malignancies in patients with chronic lymphocytic leukemiaEuropean Journal of Haematology, 1994
- Interleukin-7 Gene Transfer in Patients with Metastatic Colon Carcinoma, Renal Cell Carcinoma, Melanoma, or with Lymphoma. Universitaetsklinikum Rudolf Virchow, Standort Charlottenburg, GermanyHuman Gene Therapy, 1994
- The Clinical Experience with Interleukin-2 in Cancer TherapyCancer Biotherapy, 1994
- Second Cancers Among Long-term Survivors of Non-Hodgkin's LymphomaJNCI: Journal of the National Cancer Institute, 1993
- Forty-year experience with second malignancies after treatment of childhood cancer: Analysis of outcome following the development of the second malignancyJournal of Pediatric Surgery, 1993
- Estimates of the worldwide incidence of eighteen major cancers in 1985International Journal of Cancer, 1993
- Second Malignancies Following Treatment in non-Hodgkin's LymphomaLeukemia & Lymphoma, 1993
- Second malignant neoplasms in patients with non hodgkin's lymphomaHematological Oncology, 1991
- Second Malignant Lymphomas and Leukemias in the National Cancer Center from 1962 to 1987Japanese Journal of Cancer Research, 1990
- Decreased Risk of Subsequent Primary Noncutaneous Malignancies among Patients with Primary Cutaneous Malignant MelanomaThe Journal of Dermatologic Surgery and Oncology, 1985